SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-019802
Filing Date
2023-01-31
Accepted
2023-01-31 09:25:34
Documents
16
Period of Report
2023-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d427052d8k.htm   iXBRL 8-K 59429
2 EX-10.3 d427052dex103.htm EX-10.3 983599
3 EX-10.4 d427052dex104.htm EX-10.4 63682
4 EX-10.7 d427052dex107.htm EX-10.7 31878
5 EX-10.9 d427052dex109.htm EX-10.9 19035
  Complete submission text file 0001193125-23-019802.txt   1563406

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acer-20230130.xsd EX-101.SCH 2847
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20230130_lab.xml EX-101.LAB 18757
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20230130_pre.xml EX-101.PRE 11708
10 EXTRACTED XBRL INSTANCE DOCUMENT d427052d8k_htm.xml XML 3485
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 23570461
SIC: 2834 Pharmaceutical Preparations